Fibro test and Fibro Max test are non-invasive methods of diagnosing liver, based on blood sample – diagnosis of liver disease with biomarkers from serum, easy to use and providing high accuracy results. With over two million tests performed worldwide and over 280 scientific studies, FibroTest and FibroMax are intensively used in clinical practice by hepatologists, infectious disease specialists and gastroenterologists.
The FibroMax test is a complete diagnostic test for the liver. The five main tests are included in the FibroMax diagnostic panel test, for a complete assessment of liver status and the five main causes of liver disease. FibroMax = FibroTest’s AktoTest SSteatoTest NashTest AshAstTest Metabolic diseases, steatosis Liver steatosis, which is assessed by SteatoTest, is an accumulation of fat in the liver, often resulting in increased levels of gamma-GT, ALT and AST.
Non-alcoholic steatohepatitis (NSAID) is an inflammatory disease of the liver, which is caused by metabolic factors, including overweight, hypertension (high blood pressure), and increased triglyceride or cholesterol concentration. SHJA Test assesses the level of inflammatory necrosis activity, caused by metabolic factors.
Alcoholic steatohepatitis-hepatitis (SHA) is an inflammatory disease of the liver caused by excessive alcohol consumption. ShaTesti assesses the level of inflammatory activity that arises as a result of alcoholism. FibroTest and ActiTest are an integral part of the FibroMax test.
The FibroMax test includes 10 parameters, 5 results (combining ten standard biomarkers from serum): – Gamma-GT – Total bilirubin – Alpha-2-macroglobulin – Apolipoprotein A1 – Haptoglobin – Alanine aminotransferase (ALT) – Aspartate Aminotransferase – Cholesterol – Glucose These markers are calculated depending on the age, sex, weight and height of the patient.
Blood sampling for the FibroTest and FibroMax test should be performed in the morning on an empty stomach and on an empty stomach. FibroTest is approved and recommended by the European Society for the Study of the Liver (EASL), Diabetes (EASD) and Obesity (EASO), for the purpose of assessing fibrosis in patients suffering from metabolic disorders (NAFLD) and EASL and for evaluating patients with who consume a lot of alcohol. FibroTest and FibroMax are non-invasive tests that are applicable to most patients (98%). They are available separately. For the price of each of these two tests, see the AvicenaKS lab price list.
AvicenaKS Laboratory is a center of excellence. Vision, perseverance, and innovation are what represents us. The professionalism and dedication of the doctors in Avicena Laboratory enable all patients specialized medical service in the highest standards that medicine offers today. The heart of our laboratory is the patients and their needs.